Stifel Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $18
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
Stifel analyst James Condulis initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating and announces Price Target of $18.
Stifel analyst James Condulis initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating and announces Price Target of $18.